Augmentation of response to nab-paclitaxel by inhibition of insulin-like growth factor (IGF) signaling in preclinical pancreatic cancer models

por Awasthi, Niranjan, Scire, Emily, Monahan, Sheena, Grojean, Meghan, Zhang, Eric, Schwarz, Margaret A., Schwarz, Roderich E.
Publicado 2016

Targeted dual inhibition of c‐Met/VEGFR2 signalling by foretinib improves antitumour effects of nanoparticle paclitaxel in gastric cancer models

por Grojean, Meghan, Schwarz, Margaret A., Schwarz, Johann R., Hassan, Sazzad, von Holzen U, Zhang, Changhua, Schwarz, Roderich E., Awasthi, Niranjan
Publicado 2021